In one paragraphArticle in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Francisco TejerinaClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0002-4136-3575 Daniel Peñas-UtrillaClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0002-4454-4638 Marta HerranzClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Pilar CatalánClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Mercedes MarínClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0001-8639-5215 Lara MesonesClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0002-9453-0656 José Manuel García-DomínguezDepartment of Neurology, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0002-5205-3652 Beatriz MerinoGastroenterology Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Leire PérezClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Chiara FanciulliClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0003-2175-9027 Patricia MuñozClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0001-5706-5583 Carmen Rodríguez-GonzalezPharmacy Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Cristina DiezClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0002-3508-9979 Teresa AldámizClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0002-4374-6940 Andrea Molero-SalinasClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Darío García de ViedmaClinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0003-3647-7110 Funding
Fundación Mutua Madrileña Project FMM22/01
6 · The paper itselfAbstract
In a patient on immunosuppressant treatment, SARS-CoV-2 RNA was documented in different extra-respiratory samples over several months in the absence of positive determinations in upper respiratory samples. Whole-genome sequencing of these samples showed the acquisition of different single-nucleotide polymorphisms over time, suggesting viral evolution and thus viral viability.
Indexed as
COVID-19Immunocompromised HostSARS-CoV-2Chronic DiseaseFemaleGenome, ViralHumansImmunosuppressive AgentsMaleMiddle AgedPolymorphism, Single NucleotideRNA, ViralWhole Genome SequencingImmunosuppressive AgentsRNA, Viralimmunocompromisedpersistent COVID-19systemic infection
Identifiers
PMID40006902
PMCPMC11860550
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390